Beverly S. Mitchell - Concepedia

Author

Beverly S. Mitchell

University of North Carolina at Chapel Hill ORCID

Also Known As

B Mitchell, B S Mitchell, B. Mitchell, B. S. Mitchell, B.S. Mitchell, BEVERLY S. MITCHELL, Beaux Mitchell, Beverly Mitchell, Beverly S Mitchell, Beverly S. Mitchell

209

Publications

7.9K

Citations

H-Index

103

Concepts

All Affiliations

University of North Carolina at Chapel Hill University of Michigan Stanford University UNC Lineberger Comprehensive Cancer Center Memorial Sloan Kettering Cancer Center

About

Beverly S. Mitchell is an author at University of North Carolina at Chapel Hill specializing in medicine, cell biology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	38	2.4K
2	Natural Sciences	16	17	1.4K
3	Health Sciences	3	3	150
4	Education	1	1	32
5	Engineering	1	1	81

Beverly S. Mitchell

Publications

6.8K

Citations

H-Index

Page 1

	Year	Citations
Phase I Trial of the Proteasome Inhibitor PS-341 in Patients With Refractory Hematologic Malignancies Robert Z. Orlowski, Thomas E. Stinchcombe, Beverly S. Mitchell, Journal of Clinical Oncology	2002	760
Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies Robert Z. Orlowski, Peter M. Voorhees, Reynaldo Garcia, Blood	2004	319
Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801 Daniel J. DeAngelo, Daohai Yu, Jeffrey L. Johnson, Blood	2007	307
Association of DNA Polymerase μ (pol μ) with Ku and Ligase IV: Role for pol μ in End-Joining Double-Strand Break Repair Kiran Mahajan, Stephanie A. Nick McElhinny, Beverly S. Mitchell, Molecular and Cellular Biology Ligase IvGeneticsXrcc4-ligase IvMolecular BiologyPol μ	2002	287
Phase I Study of 506U78 Administered on a Consecutive 5-Day Schedule in Children and Adults With Refractory Hematologic Malignancies Joanne Kurtzberg, T J Ernst, Michael J. Keating, Journal of Clinical Oncology	2005	174
Guanine ribonucleotide depletion inhibits T cell activation. Mechanism of action of the immunosuppressive drug mizoribine. Laurence A. Turka, Julia Dayton, Graham Sinclair, Journal of Clinical Investigation T Cell ActivationCell TherapyMedicineImmunosuppressive TherapyImmunology	1991	156
Cloning and expression of human deoxycytidine kinase cDNA. E G Chottiner, Donna S. Shewach, N S Datta, Proceedings of the National Academy of Sciences Dcyd Kinase ActivityCell RegulationBiochemistryDcyd KinaseNatural Sciences	1991	144
Inhibition of Purine Nucleoside Phosphorylase by 8-Aminoguanosine: Selective Toxicity for T Lymphoblasts Irene S. Kazmers, Beverly S. Mitchell, Peter E. Dadonna, Science	1981	142
Failed self-tolerance and autoimmunity in IgG anti-DNA transgenic mice Betty P. Tsao, Kazuo Ohnishi, Hilde Cheroutre, The Journal of Immunology	1992	129
Regulation of the Interaction of Inosine Monophosphate Dehydrogenase with Mycophenolic Acid by GTP Yan-Shan Ji, JingJin Gu, Alexander M. Makhov, Journal of Biological Chemistry CytoskeletonIntracellular GtpRedox BiologyCellular PhysiologyOxidative Stress	2005	129

Page 1